
3
Inhaltsverzeichnis
1 Einleitung ........................................................................................................... 5
1.1 Die humanen Immundefizienzviren ..................................................................................... 5
1.1.1 Vorkommen und Verbreitung von HIV .......................................................................... 5
1.1.2 Diversität von HIV ......................................................................................................... 6
1.1.3 Transmission von HIV ................................................................................................... 6
1.1.4 Maßnahmen zur Reduktion der vertikalen Transmission von HIV ............................... 7
1.2 Antiretrovirale Medikamente gegen HIV ............................................................................ 8
1.2.1 Antiretrovirale Therapie .................................................................................................. 9
1.2.2 Antiretrovirale Prophylaxeregime für die vertikale HIV-Transmission ....................... 9
1.3 HIV-Resistenzen gegen antiretovirale Medikamente ....................................................... 12
1.3.1 Entstehung von Resistenzen .......................................................................................... 13
1.3.2 Übertragung und Persistenz von Resistenzen ................................................................ 15
1.3.3 Methoden der Resistenzbestimmung ............................................................................. 16
2Zielsetzung ....................................................................................................... 18
3Ergebnisse ........................................................................................................ 20
3.1 Liste aller Einzelarbeiten ..................................................................................................... 20
3.2 Eigenanteil an den Einzelarbeiten ...................................................................................... 21
3.3 Manuskript I - Abstract ....................................................................................................... 22
Detection and quantification of minor human immunodeficiency virus type 1
variants harboring K103N and Y181C resistance mutations in subtype A and D
isolates by allele-specific real-time PCR.
3.4 Manuskript II - Abstract ..................................................................................................... 23
Emergence and persistence of minor drug-resistant HIV-1 variants in Ugandan
women after nevirapine single-dose prophylaxis.
3.5 Manuskript III - Abstract .................................................................................................... 24
Dynamics of NVP-resistance development in HIV of Ugandan mother-child pairs
during 18 months after nevirapine single-dose exposure to reduce vertical
transmission.
3.6 Manuskript IV - Abstract .................................................................................................... 25
Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-
infected Ugandan women after nevirapine single-dose prophylaxis.
Inhaltsverzeichnis
Comentarios a estos manuales